New Treatment Approaches Valuable For Cancer Pain, Quality Of Life
High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer
Implantable Drug Delivery Device Offers Better Pain Relief
New Drug Reverses Damage To Liver In Stem Cell Transplant
New Approach To Replacing Immune Cells Shrinks Tumors
IL13-PE38 Looks Promising In Early Tests Against Gioma
US Oncology Begins Trial Of Taxotere And Xeloda
Clinical Trials Approved In August 2002 By NCI
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









